Wave Life Sciences is a clinical stage genetic medicine company. The Company is utilizing its synthetic chemistry platform to design and develop nucleic acid therapeutics that precisely target the underlying cause of rare genetic diseases, with a goal of delivering new and exceptional treatment options for patients. Wave’s pipeline spans multiple oligonucleotide modalities including antisense, exon-skipping and single-stranded RNAi, potentially enabling it to address a broad range of therapeutic areas and diseases.